GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

NCT05316935 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Neoplasms
Atypical Endometrial Hyperplasia
Progesterone Resistance

Interventions

DRUG: GnRHa
DRUG: Letrozole 2.5mg
DRUG: Diane-35
DRUG: MET

Sponsor

Xiaojun Chen